What Do Analysts Say About Lipocine Inc. (LPCN)


Lipocine Inc. (LPCN) will report its next earnings on Feb 07 AMC. The company reported the earnings of $-0.22/Share in the last quarter where the estimated EPS by analysts was $-0.21/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -4.8%.

Many analysts are providing their Estimated Earnings analysis for Lipocine Inc. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $-0.21/share. These analysts have also projected a Low Estimate of $-0.21/share and a High Estimate of $-0.2/share.

Some buy side analysts are also providing their Analysis on Lipocine Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Lipocine Inc. might touch $15 high while the Average Price Target and Low price Target is $12 and $10 respectively.

The Relative Volume of the company is 15.46 and Average Volume (3 months) is 323.77 million.

The company shows its Return on Assets (ROA) value of -68.4%. The Return on Equity (ROE) value stands at -74.6%.

While looking at the Stock’s Performance, Lipocine Inc. currently shows a Weekly Performance of -44.84%, where Monthly Performance is -47.62%, Quarterly performance is -54.61%, 6 Months performance is -58.17% and yearly performance percentage is -45.16%. Year to Date performance value (YTD perf) value is -45.64%. The Stock currently has a Weekly Volatility of 16.99% and Monthly Volatility of 7.10%.